<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36485/1561-6274-2020-24-3-42-53</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1826</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Клинико-генетические характеристики Bartter и Gitelman синдромов у детей</article-title><trans-title-group xml:lang="en"><trans-title>Clinico-genetic specifications of Bartter and Gitelman syndrome in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5881-0124</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Левиашвили</surname><given-names>Ж. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Leviashvili</surname><given-names>J. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф. Левиашвили Жанна Гавриловна, д-р мед. наук, кафедра факультетской педиатрии, профессор</p><p>194100, Санкт-Петербург, ул. Литовская, д. 2</p><p>Тел.: +7(812)416-52-66</p></bio><bio xml:lang="en"><p>Prof. Janna G. Leviashvili, MD, PhD, DMedSci, Department of Faculty Pediatrics, professor</p><p>194100, St. Petersburg, Litovskaya st. 2</p><p>Phone: +7(812)416-52-66</p></bio><email xlink:type="simple">Jannalevi@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9415-4785</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савенкова</surname><given-names>Н. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Savenkova</surname><given-names>N. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Проф. Савенкова Надежда Дмитриевна, д-р мед. наук, кафедра факультетской педиатрии, заведующая кафедрой</p><p>194100, Санкт-Петербург, ул. Литовская, д. 2</p><p>Тел.: +7(812)416-52-86</p></bio><bio xml:lang="en"><p>Prof. Nadezhda D. Savenkova, MD, PhD, DMedSci, Head of the Department of Faculty Pediatrics</p><p>194100, St. Petersburg, Litovskaya st. 2</p><p>Phone: +7(812)416-52-86</p></bio><email xlink:type="simple">Savenkova.n.spb@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Санкт-Петербурский государственный педиатрический медицинский универститет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint-Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>22</day><month>04</month><year>2020</year></pub-date><volume>24</volume><issue>3</issue><fpage>42</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Левиашвили Ж.Г., Савенкова Н.Д., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Левиашвили Ж.Г., Савенкова Н.Д.</copyright-holder><copyright-holder xml:lang="en">Leviashvili J.G., Savenkova N.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1826">https://journal.nephrolog.ru/jour/article/view/1826</self-uri><abstract><p>Молекулярно-генетическое исследование привело к открытию новых генов, кодирующих белки, – транспортеры, котранспортеры и обмениватели, участвующие в транспорте натрия, калия и хлора в толстой восходящей части петли Генле и дистальном извитом канальце. В статье представлены современные данные литературы о генетических типах тубулопатии с ведущим синдромом гипокалиемии и алкалоза – Bartter и Gitelman синдромов у детей. Описаны клинико-генетические особенности шести типов Bartter синдрома с аутосомно-рецессивным и Х-сцепленным типом наследования, подходы к классификации, диагностика и современные методы лечения. С момента первого описания Bartter синдрома известны 6 клинико-генетических вариантов, среди них антенатальные I, II, IVa, IVb, V типы, которые являются потенциально опасными для жизни заболеваниями. Bartter синдром III типа характеризуется манифестацией гипокалиемического алкалоза у детей в раннем и дошкольном возрасте. Лечение Bartter синдрома у детей включает коррекцию водно-электролитных нарушений, применение нестероидных противовоспалительных препаратов (НПВП) для ингибирования избыточного образования почечного простагландина PgЕ 2. Gitelman синдром с аутосомно-рецессивным типом наследования манифестирует у детей в школьном возрасте, в дальнейшем у подростков и взрослых наблюдается усиление клинических проявлений (с выраженными гипомагнемическими судорогами верхних и нижних конечностей, артериальной гипертензией), требующих коррекции. В обзоре представлены клинико-генетические особенности редкой, атипичной формы аутосомно-рецессивного Gitelman синдрома с манифестацией в школьном возрасте, которая характеризуется прогрессирующими двусторонними кальцификатами субкортикальных отделов больших полушарий головного мозга, кальцификатами в базальных ганглиях и субкортикальных отделах мозжечка. В отличие от Bartter синдрома, при котором более тяжелые клинические проявления у новорожденных, грудных и детей раннего возраста, Gitelman синдром имеет тенденцию к усилению клинических проявлений у подростков и взрослых. Лечение Gitelman синдрома у детей и подростков включает коррекцию водно-электролитных нарушений, применение препаратов магния и дотацию соли.</p></abstract><trans-abstract xml:lang="en"><p>Molecular genetic research has led to the discovery of new genes encoding proteins – transporters, cotransporters and exchangers involved in the transport of sodium, potassium and chlorine in the thick ascending part of the Henle loop and in the distal convoluted tubule. The article presents modern literature data on the genetic types of tubulopathy with the leading syndrome of hypokalemia and alkalosis – Bartter and Gitelman syndromes in children. The clinical and genetic features of the six types of Bartter syndrome with autosomal recessive and X-linked inheritance, classification approaches, diagnosis, and modern treatment methods are described. Since the first description of Bartter syndrome, 6 clinical genetic options have been known, including antenatal I, II, IVa, IVb, V types, which are potentially life-threatening diseases. Bartter type III syndrome is characterized by the manifestation of hypokalemic alkalosis in children at an early and preschool age. Treatment of Bartter syndrome in children includes the correction of water – electrolyte disturbances, the use of non-steroidal anti-inflammatory drugs (NSAIDs) to inhibit the excessive formation of renal prostaglandin PgE 2. Gitelman syndrome with an autosomal recessive type of inheritance manifests itself in children at school age, later on in adolescents and adults there is an increase in clinical manifestations (with severe hypomagnesemic seizures of the upper and lower extremities, arterial hypertension) requiring correction. The review presents the clinical and genetic features of the rare, atypical form of the autosomal recessive Gitelman syndrome with a manifestation in school age, which is characterized by progressive bilateral calcifications of the subcortical parts of the cerebral hemispheres, calcifications in the basal ganglia and subcortical cerebellum. Unlike Bartter syndrome, with more severe clinical manifestations in newborns, infants and young children, Gitelman syndrome tends to increase clinical manifestations in adolescents and adults. Treatment of Gitelman syndrome in children and adolescents includes the correction of water – electrolyte disturbances, the use of magnesium preparations and salt subsidy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наследственная тубулопатия</kwd><kwd>Bartter синдром</kwd><kwd>Gitelman синдром</kwd><kwd>гипокалиемия</kwd><kwd>гипомагниемия</kwd><kwd>метаболический алкалоз</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hereditary tubulopathy</kwd><kwd>Bartter syndrome</kwd><kwd>Gitelman syndrome</kwd><kwd>hypokalemia</kwd><kwd>hypomagnesemia</kwd><kwd>metabolic alkalosis</kwd><kwd>children</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Besouw MTP, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: Questions of class. Pediatr Nephrol 2019;29. doi: 10.1007/s00467-019-04371-y [Epub ahead of print]</mixed-citation><mixed-citation xml:lang="en">Besouw MTP, Kleta R, Bockenhauer D. Bartter and Gitelman syndromes: Questions of class. Pediatr Nephrol 2019;29. doi: 10.1007/s00467-019-04371-y [Epub ahead of print]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lifton RP, School I. Molecular Genetics of Gitelman s and Bartter s Syndromes and their lmplications for Blood Pressure Variation. In: Genetic disease of the kidne. Editor: Lifton RP, Somlo S, Giebisch GH, Seldin DW, eds, Elsevier 2009;229–247. doi: 10.1016/B978-0-12-449851-8.00013-9</mixed-citation><mixed-citation xml:lang="en">Lifton RP, School I. Molecular Genetics of Gitelman s and Bartter s Syndromes and their lmplications for Blood Pressure Variation. In: Genetic disease of the kidne. Editor: Lifton RP, Somlo S, Giebisch GH, Seldin DW, eds, Elsevier 2009;229–247. doi: 10.1016/B978-0-12-449851-8.00013-9</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Waldegger S, Konrad M. Bartter-, Gitelman-, and Related Syndromes. In: Pediatric Kidney Disease Chapter. Editor: DF Geary, F Schaefer, 2016;905–920. doi: 10.1007/978-3-662-52972-0_33</mixed-citation><mixed-citation xml:lang="en">Waldegger S, Konrad M. Bartter-, Gitelman-, and Related Syndromes. In: Pediatric Kidney Disease Chapter. Editor: DF Geary, F Schaefer, 2016;905–920. doi: 10.1007/978-3-662-52972-0_33</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Emma F, van’t Hoff W G, Vici CD. Renal Manifestations of Metabolic Disordersin Children . In: Pediatric Nephrology . Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (ed.), Springer-Verlag, Berlin, Heidelberg 1569;2016–2730. doi: 10.1007/978-3-662-43596-07</mixed-citation><mixed-citation xml:lang="en">Emma F, van’t Hoff W G, Vici CD. Renal Manifestations of Metabolic Disordersin Children . In: Pediatric Nephrology . Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL (ed.), Springer-Verlag, Berlin, Heidelberg 1569;2016–2730. doi: 10.1007/978-3-662-43596-07</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sardani Y, Qin K, Haas M et al. Bartter syndrome complicated by immune complex nephropathy: case report and literature review. Pediatr Nephrol 2003;18(9):913–918</mixed-citation><mixed-citation xml:lang="en">Sardani Y, Qin K, Haas M et al. Bartter syndrome complicated by immune complex nephropathy: case report and literature review. Pediatr Nephrol 2003;18(9):913–918</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Satlin LM, Bockenhauer D. Physiology of the developing kidney: potassium homeostasis and its disorder. In: Pediatric Nephrology. Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein FL (eds) Springer-Verlag, Berlin, 2016;219– 246. doi: 10.1007/978-3-662-43596-07</mixed-citation><mixed-citation xml:lang="en">Satlin LM, Bockenhauer D. Physiology of the developing kidney: potassium homeostasis and its disorder. In: Pediatric Nephrology. Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein FL (eds) Springer-Verlag, Berlin, 2016;219– 246. doi: 10.1007/978-3-662-43596-07</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008;4(10):560–567. doi: 10.1038/ncpneph0912</mixed-citation><mixed-citation xml:lang="en">Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol 2008;4(10):560–567. doi: 10.1038/ncpneph0912</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Seyberth HW, Weber S, Komhoff M. Bartters and Gitelmans syndrome. Curr Opin Pediatr 2017;29(2):179–186. doi: 10.1097/MOP.0000000000000447</mixed-citation><mixed-citation xml:lang="en">Seyberth HW, Weber S, Komhoff M. Bartters and Gitelmans syndrome. Curr Opin Pediatr 2017;29(2):179–186. doi: 10.1097/MOP.0000000000000447</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">OMIM: Entry Search Bartter Syndrome. An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. https://www.omim.org/search/?index=entry&amp;start=1&amp;limit=10&amp;sort=score+desc%2C+prefix_sort+desc&amp;search=BARTTER+SYNDROME%2C</mixed-citation><mixed-citation xml:lang="en">OMIM: Entry Search Bartter Syndrome. An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. https://www.omim.org/search/?index=entry&amp;start=1&amp;limit=10&amp;sort=score+desc%2C+prefix_sort+desc&amp;search=BARTTER+SYNDROME%2C</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Madden N, Trachtman H. Physiology of the developing kidney: sodium and water homeostasis and its disorders. In: Pediatric Nephrology. Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein FL (eds) Springer-Verlag, Berlin, 2016;181–217 doi: 10.1007/978-3-662-43596-07</mixed-citation><mixed-citation xml:lang="en">Madden N, Trachtman H. Physiology of the developing kidney: sodium and water homeostasis and its disorders. In: Pediatric Nephrology. Editor: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein FL (eds) Springer-Verlag, Berlin, 2016;181–217 doi: 10.1007/978-3-662-43596-07</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Advances in Physiology Education 2016;40:480–490. doi: 10.1152/advan.00121.2016</mixed-citation><mixed-citation xml:lang="en">Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis. Advances in Physiology Education 2016;40:480–490. doi: 10.1152/advan.00121.2016</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mount DB. Thick ascending limb of the loop of Henle. Clin J Am Soc Nephrol 2014;9(11):1974–1986. doi: 10.2215/CJN.04480413</mixed-citation><mixed-citation xml:lang="en">Mount DB. Thick ascending limb of the loop of Henle. Clin J Am Soc Nephrol 2014;9(11):1974–1986. doi: 10.2215/CJN.04480413</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what's new, what's controversial? J Am Soc Nephrol 2018;29(3):727–739. doi: 10.1681/ASN.20170 60600</mixed-citation><mixed-citation xml:lang="en">Kleta R, Bockenhauer D. Salt-losing tubulopathies in children: what's new, what's controversial? J Am Soc Nephrol 2018;29(3):727–739. doi: 10.1681/ASN.20170 60600</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Plumb LA, Van't Hoff W, Kleta R et al. Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type IV. Lancet 2016;388(10044):631–632. doi: 10,1038/ncpneph0689</mixed-citation><mixed-citation xml:lang="en">Plumb LA, Van't Hoff W, Kleta R et al. Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type IV. Lancet 2016;388(10044):631–632. doi: 10,1038/ncpneph0689</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer BK, Bergler T, Stoelcker B, Waldegger S. Mechanisms of disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nat Clin Pract Nephrol 2008;4(1):38–46. doi: 10.1038/ncpneph0689</mixed-citation><mixed-citation xml:lang="en">Kramer BK, Bergler T, Stoelcker B, Waldegger S. Mechanisms of disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nat Clin Pract Nephrol 2008;4(1):38–46. doi: 10.1038/ncpneph0689</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh PR, Tse Y, Ashton E et al. Clinical and diagnostic features of Bartter and Gitelman syndromes. Clin Kidney J 2018;11(3):302–309. doi: 10.1093/ckj/sfx118</mixed-citation><mixed-citation xml:lang="en">Walsh PR, Tse Y, Ashton E et al. Clinical and diagnostic features of Bartter and Gitelman syndromes. Clin Kidney J 2018;11(3):302–309. doi: 10.1093/ckj/sfx118</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Koulouridis E1, Koulouridis I. Molecular pathophysiology of Bartter's and Gitelman's syndromes. World J Pediatr 2015;11(2):113–125. doi: 10.1007/s12519-015-0016-4</mixed-citation><mixed-citation xml:lang="en">Koulouridis E1, Koulouridis I. Molecular pathophysiology of Bartter's and Gitelman's syndromes. World J Pediatr 2015;11(2):113–125. doi: 10.1007/s12519-015-0016-4</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">van der Hagen EA, van Loon EP, Verkaart S et al. The Na+/Ca2+ Exchanger 1 (NCX1) Variant 3 as the major extrusion system in renal distal tubular transcellular Ca2+-transport. Nephron 2015;131(2):145–152. doi: 10.1159/000440655</mixed-citation><mixed-citation xml:lang="en">van der Hagen EA, van Loon EP, Verkaart S et al. The Na+/Ca2+ Exchanger 1 (NCX1) Variant 3 as the major extrusion system in renal distal tubular transcellular Ca2+-transport. Nephron 2015;131(2):145–152. doi: 10.1159/000440655</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">de Baaij JH. The art of magnesium transport. Magnes Res 2015;28(3):85–91. doi: 10.1684/mrh.2015.0388</mixed-citation><mixed-citation xml:lang="en">de Baaij JH. The art of magnesium transport. Magnes Res 2015;28(3):85–91. doi: 10.1684/mrh.2015.0388</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Левиашвили ЖГ, Савенкова НД. Барттер синдром у детей. Обзор литературы Нефрология 2012;16(3/2):25–33. doi: 10.24884/1561-6274-2012-16-3/2-25-33</mixed-citation><mixed-citation xml:lang="en">Leviashvili ZhG, Savenkova ND. Bartter syndrome in children. Literature Review Nephrology (Saint-Petersburg) 2012;16(3/2):25–33. (In Russ.) doi: 10.24884/1561-6274-2012-16-3/2-25-33</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bockenhauer D, Bichet DG. Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. Am J Physiol Renal Physiol 2013;304(8):F1037–F1042 doi: 10.1152/ajprenal.00639.2012</mixed-citation><mixed-citation xml:lang="en">Bockenhauer D, Bichet DG. Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. Am J Physiol Renal Physiol 2013;304(8):F1037–F1042 doi: 10.1152/ajprenal.00639.2012</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">O'Donnell BM, Mackie TD, Subramanya AR, Brodsky JL. Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome. J Biol Chem 2017;292(31):12813–12827. doi: 10.1074/jbc.M117.786376</mixed-citation><mixed-citation xml:lang="en">O'Donnell BM, Mackie TD, Subramanya AR, Brodsky JL. Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome. J Biol Chem 2017;292(31):12813–12827. doi: 10.1074/jbc.M117.786376</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Левиашвили ЖГ, Савенкова НД. Справочник по наследственным синдромам с патологией почек у детей. Под ред. НД Савенковой. Издательство «Левша. Санкт-Петербург», СПб., 2015; 104 с</mixed-citation><mixed-citation xml:lang="en">Leviashvili ZhG, Savenkova ND. Handbook of hereditary syndromes with renal pathology in children. Ed. ND Savenkova. Publishing House “Lefty. St. Petersburg”, St. Petersburg, 2015;104 p</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Левиашвили ЖГ, Савенкова НД, Левичева ОВ и др. Катамнестическое наблюдение детей с синдромом Bartter и Gitelman. Нефрология 2013;17(3):80–87. doi: 10.24884/1561-6274-2013-17-3-80-87</mixed-citation><mixed-citation xml:lang="en">Leviashvili ZhG, Savenkova ND, Levicheva OV et al. Follow-up of children with Bartter syndrome and Gitelman. Nephrology (Saint-Petersburg) 2013;17(3):80–87. (In Russ.) doi: 10.24884/1561-6274-2013-17-3-80-87</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Leviashvili ZhG, Savenkova ND. Clinical-genetic study of Bartter syndrome type 1. Abstract the sixteenth congress of the IPNA. Shanghai, August 30 – September 3, 2013. Ped Nephrology 2013;10;PSAT276#276:p130</mixed-citation><mixed-citation xml:lang="en">Leviashvili ZhG, Savenkova ND. Clinical-genetic study of Bartter syndrome type 1. Abstract the sixteenth congress of the IPNA. Shanghai, August 30 – September 3, 2013. Ped Nephrology 2013;10;PSAT276#276:p130</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Seys E, Andrini O, Keck M et al. Clinical and genetic spectrum of Bartter syndrome type 3. J Am Soc Nephrol 2017;28(8):2540–2552. doi: 10.1681/ASN.2016101057</mixed-citation><mixed-citation xml:lang="en">Seys E, Andrini O, Keck M et al. Clinical and genetic spectrum of Bartter syndrome type 3. J Am Soc Nephrol 2017;28(8):2540–2552. doi: 10.1681/ASN.2016101057</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wingo CS, Stockand JD. Alkaline activation of ClC-K2 chloride channels switches renal cells from reabsorbing to secreting. J Gen Physiol 2016;148(3):195–199. doi: 10.2215/CJN.04480413</mixed-citation><mixed-citation xml:lang="en">Wingo CS, Stockand JD. Alkaline activation of ClC-K2 chloride channels switches renal cells from reabsorbing to secreting. J Gen Physiol 2016;148(3):195–199. doi: 10.2215/CJN.04480413</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Milatz S, Himmerkus N, Wulfmeyer VC et al. Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na+ and Mg2+ transport. Proc Natl Acad Sci USA. 2017;114(2):E219–E227. doi: 10.1073/pnas.1611684114</mixed-citation><mixed-citation xml:lang="en">Milatz S, Himmerkus N, Wulfmeyer VC et al. Mosaic expression of claudins in thick ascending limbs of Henle results in spatial separation of paracellular Na+ and Mg2+ transport. Proc Natl Acad Sci USA. 2017;114(2):E219–E227. doi: 10.1073/pnas.1611684114</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Legrand A, Treard C, Roncelin I et al. Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome. Clin J Am Soc Nephrol 2018;13(2):242–250. doi: 10.2215/CJN.05670517</mixed-citation><mixed-citation xml:lang="en">Legrand A, Treard C, Roncelin I et al. Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome. Clin J Am Soc Nephrol 2018;13(2):242–250. doi: 10.2215/CJN.05670517</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Laghmani K, Beck BB, Yang SS et al. Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED2 mutations. N Engl J Med 2016;12.374(19):1853–1863. doi: 10.1056/NEJ-Moa1507629</mixed-citation><mixed-citation xml:lang="en">Laghmani K, Beck BB, Yang SS et al. Polyhydramnios, transient antenatal Bartter's syndrome, and MAGED2 mutations. N Engl J Med 2016;12.374(19):1853–1863. doi: 10.1056/NEJ-Moa1507629</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kömhoff M, Laghmani K. MAGED2: a novel form of antenatal Bartter's syndrome. Curr Opin Nephrol Hypertens 2018;27(4):323–328. doi: 10.1097/MNH.0000000000000422</mixed-citation><mixed-citation xml:lang="en">Kömhoff M, Laghmani K. MAGED2: a novel form of antenatal Bartter's syndrome. Curr Opin Nephrol Hypertens 2018;27(4):323–328. doi: 10.1097/MNH.0000000000000422</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">van der Hagen EA, Lavrijsen M, van Zeeland F et al. Coordinated regulation of TRPV5-mediated Ca(2)(+) transport in primary distal convolution cultures. Pflugers Arch 2014;466(11):2077–2087. doi: 10.1007/s00424-014-1470-x</mixed-citation><mixed-citation xml:lang="en">van der Hagen EA, Lavrijsen M, van Zeeland F et al. Coordinated regulation of TRPV5-mediated Ca(2)(+) transport in primary distal convolution cultures. Pflugers Arch 2014;466(11):2077–2087. doi: 10.1007/s00424-014-1470-x</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Devuyst O, Belge H, Konrad M et al. Renal tubular disorders of electrolyte regulation in children. Gitelman syndrome. In: Pediatric Nephrology. ED Avner (ed.). Springer-Verlag, Berlin, Heidelberg, 2016;1215–1221. doi: 10.1007/978-3-662-43596-0_341201</mixed-citation><mixed-citation xml:lang="en">Devuyst O, Belge H, Konrad M et al. Renal tubular disorders of electrolyte regulation in children. Gitelman syndrome. In: Pediatric Nephrology. ED Avner (ed.). Springer-Verlag, Berlin, Heidelberg, 2016;1215–1221. doi: 10.1007/978-3-662-43596-0_341201</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Das SK, Ghosh A, Banerjee N, Khaskil S. Gitelman’s syndrome presenting with hypocalcemia, basal ganglia calcification and periodic paralysis. Singapore Med J 2012;53:e222–e224</mixed-citation><mixed-citation xml:lang="en">Das SK, Ghosh A, Banerjee N, Khaskil S. Gitelman’s syndrome presenting with hypocalcemia, basal ganglia calcification and periodic paralysis. Singapore Med J 2012;53:e222–e224</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Riveira-Munoz E, Chang Q, Godefroid N et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007;18(4):1271–1283. doi: 10.1681/ASN.2006101095</mixed-citation><mixed-citation xml:lang="en">Riveira-Munoz E, Chang Q, Godefroid N et al. Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome. J Am Soc Nephrol 2007;18(4):1271–1283. doi: 10.1681/ASN.2006101095</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Tsutsui H, Hamano T, Kawaura Y et al. Case of Gitelman syndrome associated with idiopathic intracranial hypertension. Intern Med 2011;50:1493–1496. doi: 10.2169/internalmedicine.50.5305</mixed-citation><mixed-citation xml:lang="en">Tsutsui H, Hamano T, Kawaura Y et al. Case of Gitelman syndrome associated with idiopathic intracranial hypertension. Intern Med 2011;50:1493–1496. doi: 10.2169/internalmedicine.50.5305</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Quinlan CS, Walsh JC, Moran AM et al. Gitelman syndrome. A rare presentation mimicking cauda equina syndrome. J Bone Joint Surg Br 2011;93:266–268. doi: 10.1302/0301-620-X.93B2.25700</mixed-citation><mixed-citation xml:lang="en">Quinlan CS, Walsh JC, Moran AM et al. Gitelman syndrome. A rare presentation mimicking cauda equina syndrome. J Bone Joint Surg Br 2011;93:266–268. doi: 10.1302/0301-620-X.93B2.25700</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gandi K, Prasad D, Malhotra V, Agrawal D. Gitelman’s syndrome presenting with hypocalcemic tetany and hypokalemic periodic paralysis, case report. India Saudi J Kidney Dis Transpl 2016;27(5):1026–1028</mixed-citation><mixed-citation xml:lang="en">Gandi K, Prasad D, Malhotra V, Agrawal D. Gitelman’s syndrome presenting with hypocalcemic tetany and hypokalemic periodic paralysis, case report. India Saudi J Kidney Dis Transpl 2016;27(5):1026–1028</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Viering DHHM, de Baaij JHF, Walsh SB et al. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol 2017;32(7):1123–1135. doi: 1007/s00467-016-3416-3</mixed-citation><mixed-citation xml:lang="en">Viering DHHM, de Baaij JHF, Walsh SB et al. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol 2017;32(7):1123–1135. doi: 1007/s00467-016-3416-3</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Beltagi AEl, Norbash A, Vattoth S. Novel brain MRI abnormalities in Gitelman syndrome. Neuroradiol J 2015;28(5):523–528. doi: 10.1177/1971400915609340</mixed-citation><mixed-citation xml:lang="en">Beltagi AEl, Norbash A, Vattoth S. Novel brain MRI abnormalities in Gitelman syndrome. Neuroradiol J 2015;28(5):523–528. doi: 10.1177/1971400915609340</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Blanchard A, Bockenhauer D, Bolignano D et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Kidney International 2017;91:24–33. doi: dx.doi.org/10.1016/j.kint.2016.09.046</mixed-citation><mixed-citation xml:lang="en">Blanchard A, Bockenhauer D, Bolignano D et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Kidney International 2017;91:24–33. doi: dx.doi.org/10.1016/j.kint.2016.09.046</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Scholl UI, Dave HB, Lu M et al. SeSAME/EAST syndrome-phenotypic variability and delayed activity of the distal convoluted tubule. Pediatr Nephrol 2012;27(11):2081–2090. doi: 10.1007/s00467-012-2219-4</mixed-citation><mixed-citation xml:lang="en">Scholl UI, Dave HB, Lu M et al. SeSAME/EAST syndrome-phenotypic variability and delayed activity of the distal convoluted tubule. Pediatr Nephrol 2012;27(11):2081–2090. doi: 10.1007/s00467-012-2219-4</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Adalat S, Hayes W, Bryant WA et al. HNF1B mutations are associated with a Gitelman-like tubulopathy that develops during childhood. Kidney Int Rep 2019;4(9):1304–1311. doi: 10.1016/j.ekir.2019.05.019.e</mixed-citation><mixed-citation xml:lang="en">Adalat S, Hayes W, Bryant WA et al. HNF1B mutations are associated with a Gitelman-like tubulopathy that develops during childhood. Kidney Int Rep 2019;4(9):1304–1311. doi: 10.1016/j.ekir.2019.05.019.e</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">OMIM: An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. Baltimore: Johns Hopkins Univ, 2015; Mode of access: http://www.omim.org/</mixed-citation><mixed-citation xml:lang="en">OMIM: An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. Baltimore: Johns Hopkins Univ, 2015; Mode of access: http://www.omim.org/</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Левиашвили ЖГ, Савенкова НД, Гузева ВИ и др. Атипичная форма синдрома Гительмана с церебральными кальцификатами. Российский вестник перинатологии и педиатрии 2018;63(1):90–95. doi: 10.21508/1027-4065-2018-63-1-90-95</mixed-citation><mixed-citation xml:lang="en">Leviashvili JG, Savenkova ND, Guzeva VI et al. The atypical form of Gitelman syndrome with cerebral calcifications. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2018;63(1):90–95. (In Russ.) doi: 10.21508/1027-4065-2018-63-1-90-95</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Bockenhauer D, Feather S, Stanescu HC et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009;7;360(19):1960–1970. doi: 10.1056/NEJMoa0810276</mixed-citation><mixed-citation xml:lang="en">Bockenhauer D, Feather S, Stanescu HC et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med 2009;7;360(19):1960–1970. doi: 10.1056/NEJMoa0810276</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Himmerkus N, Plain A, Marques RD et al. AVP dynamically increases paracellular Na + permeability and transcellular NaCl transport in the medullary thick ascending limb of Henle's loop. Pflugers Arch 2017;469(1):149–158. doi: 10.1007/s00424-016-1915-5</mixed-citation><mixed-citation xml:lang="en">Himmerkus N, Plain A, Marques RD et al. AVP dynamically increases paracellular Na + permeability and transcellular NaCl transport in the medullary thick ascending limb of Henle's loop. Pflugers Arch 2017;469(1):149–158. doi: 10.1007/s00424-016-1915-5</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Calò LA, Maiolino G. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes. J Endocrinol Invest 2015;38(7):711–716. doi: 10.1007/s40618-015-0249-z</mixed-citation><mixed-citation xml:lang="en">Calò LA, Maiolino G. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes. J Endocrinol Invest 2015;38(7):711–716. doi: 10.1007/s40618-015-0249-z</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements. Nephrol Dial Transplant 2013;28(6):1533–1542. doi: 10.1093/ndt/gfs600</mixed-citation><mixed-citation xml:lang="en">Berry MR, Robinson C, Karet Frankl FE. Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements. Nephrol Dial Transplant 2013;28(6):1533–1542. doi: 10.1093/ndt/gfs600</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Bao M, Cai J, Yang X, Ma W. Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia. Clin Exp Hypertens 2019;41(4):381–388. doi: 10.1080/10641963.2018.148954</mixed-citation><mixed-citation xml:lang="en">Bao M, Cai J, Yang X, Ma W. Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia. Clin Exp Hypertens 2019;41(4):381–388. doi: 10.1080/10641963.2018.148954</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Colussi G, Rombolà G, De Ferrari ME et al. Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 1994;14:127–135. doi: 10.1159/000168701</mixed-citation><mixed-citation xml:lang="en">Colussi G, Rombolà G, De Ferrari ME et al. Correction of hypokalemia with antialdosterone therapy in Gitelman’s syndrome. Am J Nephrol 1994;14:127–135. doi: 10.1159/000168701</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">de Jong JC, Willems PH, Goossens M et al. Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman’s syndrome in a mouse cortical collecting duct cell line. Nephrol Dial Transplant 2004;19:1069–1076. doi: 10.1093/ndt/gfg474</mixed-citation><mixed-citation xml:lang="en">de Jong JC, Willems PH, Goossens M et al. Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman’s syndrome in a mouse cortical collecting duct cell line. Nephrol Dial Transplant 2004;19:1069–1076. doi: 10.1093/ndt/gfg474</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Howie AJ. Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time? Pediatr Nephrol 2020;35:9–16. doi: 10.1007/s00467-018-4161-6</mixed-citation><mixed-citation xml:lang="en">Howie AJ. Genetic studies of focal segmental glomerulosclerosis: a waste of scientific time? Pediatr Nephrol 2020;35:9–16. doi: 10.1007/s00467-018-4161-6</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Yamazaki H, Nozu K, Narita I et al. Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 2009;24:415–418. doi: 10.1007/s00467-008-0999-3</mixed-citation><mixed-citation xml:lang="en">Yamazaki H, Nozu K, Narita I et al. Atypical phenotype of type I Bartter syndrome accompanied by focal segmental glomerulosclerosis. Pediatr Nephrol 2009;24:415–418. doi: 10.1007/s00467-008-0999-3</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh PR, Tse Y, Ashton E et al. Clinical and diagnostic features of Bartter and Gitelman syndromes Clinical Kidney J 2018;11(3):302–309. doi: 10.1093/ckj/sfx118</mixed-citation><mixed-citation xml:lang="en">Walsh PR, Tse Y, Ashton E et al. Clinical and diagnostic features of Bartter and Gitelman syndromes Clinical Kidney J 2018;11(3):302–309. doi: 10.1093/ckj/sfx118</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SE, Han KH, Jung YH et al. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis. Korean J Pediatr 2011;54(1):36–39. doi: 10.3345/kjp.2011.54.1.36</mixed-citation><mixed-citation xml:lang="en">Lee SE, Han KH, Jung YH et al. Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis. Korean J Pediatr 2011;54(1):36–39. doi: 10.3345/kjp.2011.54.1.36</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Каюков ИГ, Смирнов АВ, Шабунин МА и др. Редкие заболевания в практике «взрослого» нефролога: состояния, ассоциированные с гипокалиемией. Сообщение III. Синдромы Барттера и Гительмана Нефрология 2009;13(1):86–102. doi: 10.24884/1561-6274-2009-13-4-86-102</mixed-citation><mixed-citation xml:lang="en">Kayukov IG, Smirnov AV, Shabunin MA et al. Rare diseases in the practice of an “adult” nephrologist: conditions associated with hypokalemia. Message III. Bartter and Gitelman Syndromes Nephrology (Saint-Petersburg) 2009;13(1):86–102. (In Russ.) doi: 10.24884/1561-6274-2009-13-4-86-102</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
